Literature DB >> 10101556

Risk factors for predicting mortality in a paediatric intensive care unit.

G H Tan1, T H Tan, D Y Goh, H K Yap.   

Abstract

Rapid advances in critical care technology and rising cost of medical care have spurred the development of outcome analysis including mortality risk prediction. The main objective of this study was to assess the risk factors contributing to mortality in our paediatric intensive care unit (PICU). This is a cohort study, consisting of consecutive admissions to the PICU from 1 January to 31 December 1997. The factors studied included multi-organ dysfunction syndrome (MODS), Pediatric Risk of Mortality III (PRISM III) scores in the first 24 hours (PRISM III-24), mechanical ventilation, renal replacement therapy, age, and diagnosis-related groups. Univariate and multivariate statistical methods were used. Univariate analysis showed that need for mechanical ventilation, renal replacement therapy, presence of MODS involving 3 or more organs and PRISM III-24 scores were significantly associated with outcome (P < 0.0005). Relative risk of mortality in the presence of MODS and PRISM III-24 scores > or = 8 were 11.3 (95% CI: 3.3 to 38.3) and 15.8 (95% CI: 2.0 to 127.8), respectively. Using Cox Proportional Hazards model, the relative risk of mortality for any new admission could be calculated by the equation RR = e0.1032 x P, where P = PRISM III-24 scores.

Entities:  

Mesh:

Year:  1998        PMID: 10101556

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  9 in total

1.  Clinical characteristics and mortality risk prediction in critically ill children in Malaysian Borneo.

Authors:  Indra Ganesan; Terrence Thomas; Fon En Ng; Thian Lian Soo
Journal:  Singapore Med J       Date:  2014-05       Impact factor: 1.858

Review 2.  Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome.

Authors:  R Scott Watson; Sheri S Crow; Mary E Hartman; Jacques Lacroix; Folafoluwa O Odetola
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

3.  Demographic profile and outcome analysis of pediatric intensive care patients.

Authors:  E Volakli; M Sdougka; M Tamiolaki; C Tsonidis; M Reizoglou; M Giala
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

4.  Hypertension and health outcomes in the PICU.

Authors:  Brett J Ehrmann; David T Selewski; Jonathan P Troost; Susan M Hieber; Debbie S Gipson
Journal:  Pediatr Crit Care Med       Date:  2014-06       Impact factor: 3.624

5.  Application of the pediatric risk of mortality (PRISM) score and determination of mortality risk factors in a tertiary pediatric intensive care unit.

Authors:  Graziela Araujo Costa; Arthur F Delgado; Alexandre Ferraro; Thelma Suely Okay
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

6.  U-shaped relationship between early blood glucose and mortality in critically ill children.

Authors:  Yanhong Li; Zhenjiang Bai; Mengxia Li; Xueqin Wang; Jian Pan; Xiaozhong Li; Jian Wang; Xing Feng
Journal:  BMC Pediatr       Date:  2015-07-24       Impact factor: 2.125

7.  Effectiveness of predicting in-hospital mortality in critically ill children by assessing blood lactate levels at admission.

Authors:  Zhenjiang Bai; Xueping Zhu; Mengxia Li; Jun Hua; Ying Li; Jian Pan; Jian Wang; Yanhong Li
Journal:  BMC Pediatr       Date:  2014-03-28       Impact factor: 2.125

8.  Mortality risk prediction by application of pediatric risk of mortality scoring system in pediatric intensive care unit.

Authors:  Ali Khajeh; Noor Mohammad Noori; Mohsen Reisi; Afshin Fayyazi; Mahdi Mohammadi; Ghasem Miri-Aliabad
Journal:  Iran J Pediatr       Date:  2013-10       Impact factor: 0.364

9.  Multiple organ dysfunction syndrome in critically ill children: clinical value of two lists of diagnostic criteria.

Authors:  Andréanne Villeneuve; Jean-Sébastien Joyal; François Proulx; Thierry Ducruet; Nicole Poitras; Jacques Lacroix
Journal:  Ann Intensive Care       Date:  2016-04-29       Impact factor: 6.925

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.